학술논문
1878P Health-related quality of life (HRQoL) assessment for patients with advanced renal cell carcinoma (aRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient reported outcomes in daily clinical practice: QUANARIE trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S1069-S1069
Subject
Language
ISSN
0923-7534